Q: Retired, dividend-income investor. I've been building a position in HHL for the last 6 months and am ready to add the final 10% tranche.
So, for asset allocation purposes, I can convince myself to go ahead. Add to that, the prices paid in the past (averaging $7.97) have all been higher than now ($7.18)....if I liked it at $8/share, then I should really like it at $7...right?
On the flip side, I don't trust what the USA admin is doing now. I can easily convince myself to leave things as they are now and pause buying more. Then it becomes a market timing question...sort of.
I am leaning towards sitting on my hands for a few more months. Your thoughts....thanks. Steve
So, for asset allocation purposes, I can convince myself to go ahead. Add to that, the prices paid in the past (averaging $7.97) have all been higher than now ($7.18)....if I liked it at $8/share, then I should really like it at $7...right?
On the flip side, I don't trust what the USA admin is doing now. I can easily convince myself to leave things as they are now and pause buying more. Then it becomes a market timing question...sort of.
I am leaning towards sitting on my hands for a few more months. Your thoughts....thanks. Steve
5i Research Answer:
As a diversified ETF focused on healthcare, we wouldn't be too concerned on timing here. Healthcare is in the doldrums currently but we don't think the prospects have fundamentally changed and even if one were to make that argument, the weakness should account for some of this impact already in theory as well.